AstraZeneca from the UK is the leading vaccine candidate with it already in the final phase of trial and expected to roll out the vaccines by December 2020 or January 2021. Other Contenders are Moderna Inc, Pfizer Inc with partner BioNTech SE, and Johnson & Johnson.